| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | etoposide | GDSC1000 | pan-cancer | AAC | -0.08 | 0.02 |
| mRNA | selumetinib:MK-2206 (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.081 | 0.02 |
| mRNA | GSK1059615 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.03 |
| mRNA | Nutlin-3 | CTRPv2 | pan-cancer | AAC | -0.078 | 0.03 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | -0.099 | 0.03 |
| mRNA | GW-405833 | CTRPv2 | pan-cancer | AAC | 0.076 | 0.03 |
| mRNA | ruxolitinib | GDSC1000 | pan-cancer | AAC | -0.072 | 0.03 |
| mRNA | KU-55933 | CTRPv2 | pan-cancer | AAC | 0.079 | 0.03 |
| mRNA | BRD-K51490254 | CTRPv2 | pan-cancer | AAC | 0.082 | 0.03 |
| mRNA | BIBW2992 | FIMM | pan-cancer | AAC | -0.32 | 0.03 |